BioSpace News Archive

Allergan Presents New Research at the American College of Gastroenterology Annual Scientific Meeting (ACG 2018)

American College of Gastroenterology Annual Scientific Meeting (ACG), from October 5-10, 2018 in Philadelphia, PA.

October 8, 2018
·
7 min read
Deals

BioIVT Acquires UK-based Clinical Trials Laboratory Services

BioIVT, a leading provider of research models and services for drug development, today announced that it has acquired Clinical Trials Laboratory Services (CTLS), a donor center and laboratory based in London, UK

October 8, 2018
·
3 min read
BioMidwest

New Real-World Data Analyses Support the Long-Term Use of Entyvio® (vedolizumab) in Bio-Naïve Patients for the Treatment of Moderate to Severe Ulcerative Colitis or Crohn’s Disease

A total of 10 Entyvio abstracts were accepted for presentation at the meeting.

October 8, 2018
·
10 min read
Pharm Country

Salix to Present Clinical Data for XIFAXAN® (RIFAXIMIN) and PLENVU® at the American College of Gastroenterology Annual Meeting

Salix Pharmaceuticals (“Salix”), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases and a wholly owned subsidiary of Bausch Health Companies Inc.

October 8, 2018
·
11 min read
Genetown

CSA Medical Secures $23 Million to Advance its Cryospray™ Therapies for Esophageal Disease and COPD

CSA Medical Inc. announced that it has secured $23 million in venture debt and equity financing to advance its two novel cryospray therapy platforms, truFreeze and Rejuvenair.

October 8, 2018
·
3 min read
Business

Sebacia Highlights Oral Presentation of EU Real-World Pre-Conditioning Study Results at ASDS Annual Meeting 2018

Sebacia, Inc., a privately held, commercial stage dermatology and aesthetics company, today announced that results from its real-world pre-conditioning study in Europe evaluating Sebacia Microparticles for treatment of facial acne has been accepted for an oral presentation

October 8, 2018
·
2 min read
Biotech Bay

Ardelyx Showcases New Data from T3MPO-3 Long-Term Safety Trial of Tenapanor for IBS-C in Presidential Poster at ACG 2018 Annual Meeting

Ardelyx, Inc. (Nasdaq: ARDX), today announced that new data from its long-term safety trial of tenapanor for irritable bowel syndrome with constipation (IBS-C), the T3MPO-3 trial, were presented this weekend at the American College of Gastroenterology (ACG) 2018 Annual Meeting.

October 8, 2018
·
6 min read
Immunovia Announces Strategic Focus Centered on IMMray™ Blood-based Biomarker Signatures for Rheumatoid Arthritis Within Autoimmunity

Encouraged by the promising discovery study results previously reported, Immunovia´s prime focus in autoimmunity testing will be to develop IMMray™ blood-based biomarker signatures for the management of rheumatoid arthritis.

October 8, 2018
·
6 min read
Business

DexCom Schedules Third Quarter 2018 Earnings Release and Conference Call for November 6, 2018 at 4:30 p.m. Eastern Time.

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2018 financial results after market close on Tuesday, November 6, 2018.

October 8, 2018
·
1 min read
BioCapital

Research and Education’s Technical Community to Gather in Orlando for the 2018 Internet2 Technology Exchange

Meeting program includes 83 technical presentations, 78 working meetings, four advanced networking demonstrations, nine in-depth tutorials, and six co-located events

October 8, 2018
·
2 min read